Home › Employers › Evidence for Healthcare Improvement
Evidence for Healthcare Improvement: H-1B salaries and sponsorship
Evidence for Healthcare Improvement filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $114,856.
Does Evidence for Healthcare Improvement sponsor H-1B visas?
Evidence for Healthcare Improvement filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on Jan 15, 2025. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.
Salaries by job title
| Job title | LCAs | Median salary |
|---|---|---|
| Research Scientist | 1 | $114,856 |
| Associate Director of Health Economics and Decision Modeling | 1 | $155,000 |
| Senior Research Lead | 1 | $113,957 |
Applications by fiscal year
| Fiscal year | LCAs | Median salary |
|---|---|---|
| FY2024 | 1 | $114,856 |
| FY2025 | 2 | $134,478 |
Prevailing wage levels
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Where the jobs are
Occupations
Latest applications
| Job title | Base salary | Location | Submitted | Start date | Status |
|---|---|---|---|---|---|
| Senior Research Lead | $113,957 Level II | Auburn, AL | Jan 15, 2025 | Jul 4, 2025 | Certified |
| Associate Director of Health Economics and Decision Modeling | $155,000 Level II | Boston, MA | Nov 13, 2024 | Apr 1, 2025 | Certified |
| Research Scientist | $114,856 Level III | Boston, MA | Feb 14, 2024 | Jun 22, 2024 | Certified |
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).